U.S. Chamber comments on the Centers for Medicare & Medicaid Services' ("CMS's") Draft Guidance implementing Initial Price Applicability Year 2028 ("IPAY 2028") of the Medicare Drug Price Negotiation Program created by the Biden Administration under the Inflation Reduction Act ("IRA").
Recommended
- Intellectual Property
A $460 Billion Problem: Combating Counterfeits Takes Every Player on the Field
The Global Innovation Policy Center convened leaders from the intellectual property enforcement, trade, and professional sports communities to address the growing threat of counterfeiting around global sporting events.
By Adam Sulewski
- Health Care
Breast Cancer's $25 Trillion Miracle—and Why It's at Risk
By Kelly Anderson
View this online
